Announced Wed, 18 Feb · 20:07 IST

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We are delighted to inform you that the Company has obtained certificates in respect ....

Business Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sudarshan Pharma Industries has received two quality certifications for its API manufacturing facility located at IDA-Medchal, Hyderabad, Telangana. The company secured a Good Manufacturing Practice (GMP) Certificate of Compliance from UK Certification & Inspection Limited for manufacturing API Intermediates and Active Pharmaceutical Ingredients. Additionally, it received an ISO 9001:2015 Quality Management System certification from Staunchly Management and System Services Private Limited. Both certifications were issued on February 12, 2026, and remain valid until February 11, 2029.

Likely market impact

This is a positive operational milestone that validates the company's manufacturing quality standards and strengthens its credibility as a compliant API manufacturer, which could support future business and export opportunities. No immediate financial impact, but it is a constructive signal for long-term positioning.